328 related articles for article (PubMed ID: 16393302)
1. Upper gastrointestinal bleeding associated with antiplatelet drugs.
Ibáñez L; Vidal X; Vendrell L; Moretti U; Laporte JR;
Aliment Pharmacol Ther; 2006 Jan; 23(2):235-42. PubMed ID: 16393302
[TBL] [Abstract][Full Text] [Related]
2. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
3. Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding.
Delaney JA; Opatrny L; Brophy JM; Suissa S
CMAJ; 2007 Aug; 177(4):347-51. PubMed ID: 17698822
[TBL] [Abstract][Full Text] [Related]
4. Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding.
Lanas A; Bajador E; Serrano P; Fuentes J; Carreño S; Guardia J; Sanz M; Montoro M; Sáinz R
N Engl J Med; 2000 Sep; 343(12):834-9. PubMed ID: 10995862
[TBL] [Abstract][Full Text] [Related]
5. PPI use in patients commenced on clopidogrel: a retrospective cross-sectional evaluation.
Luinstra M; Naunton M; Peterson GM; Bereznicki L
J Clin Pharm Ther; 2010 Apr; 35(2):213-7. PubMed ID: 20456741
[TBL] [Abstract][Full Text] [Related]
6. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants.
Lanas A; García-Rodríguez LA; Arroyo MT; Bujanda L; Gomollón F; Forné M; Aleman S; Nicolas D; Feu F; González-Pérez A; Borda A; Castro M; Poveda MJ; Arenas J;
Am J Gastroenterol; 2007 Mar; 102(3):507-15. PubMed ID: 17338735
[TBL] [Abstract][Full Text] [Related]
7. A case-control study of the association between polymorphisms of the endothelial nitric oxide synthase and glycoprotein IIIa genes and upper gastrointestinal bleeding in users of low-dose aspirin.
Piazuelo E; Fuentes J; García-González MA; Jiménez P; Lanas A
Clin Ther; 2008 Jan; 30(1):121-30. PubMed ID: 18343248
[TBL] [Abstract][Full Text] [Related]
8. Risk of massive upper gastrointestinal bleeding in gastric bypass patients taking clopidogrel.
Caruana JA; McCabe MN; Smith AD; Panemanglore VP; Sette Camara D
Surg Obes Relat Dis; 2007; 3(4):443-5. PubMed ID: 17400519
[TBL] [Abstract][Full Text] [Related]
9. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
Hsu PI
J Gastroenterol Hepatol; 2012 Apr; 27(4):654-61. PubMed ID: 22283743
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal bleeding in patients receiving a combination of aspirin, clopidogrel, and enoxaparin in acute coronary syndrome.
Ng FH; Wong SY; Lam KF; Chang CM; Lau YK; Chu WM; Wong BC
Am J Gastroenterol; 2008 Apr; 103(4):865-71. PubMed ID: 18177451
[TBL] [Abstract][Full Text] [Related]
11. [Risk factors of upper gastrointestinal complications in outpatients on antiplatelet therapy: description and management].
Ducrocq G; Bigard MA; Marouene S; Delaage PH; Fabry C; Barthelemy P; Steg PG;
Ann Cardiol Angeiol (Paris); 2012 Aug; 61(4):245-51. PubMed ID: 22579299
[TBL] [Abstract][Full Text] [Related]
12. Strategies to reduce the GI risks of antiplatelet therapy.
Scheiman JM
Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
[TBL] [Abstract][Full Text] [Related]
13. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
Aronow HD; Steinhubl SR; Brennan DM; Berger PB; Topol EJ;
Am Heart J; 2009 Feb; 157(2):369-74. PubMed ID: 19185647
[TBL] [Abstract][Full Text] [Related]
14. Single antiplatelet therapy for patients with previous gastrointestinal bleeds.
Gellatly RM; Ackman ML
Ann Pharmacother; 2008 Jun; 42(6):836-40. PubMed ID: 18413689
[TBL] [Abstract][Full Text] [Related]
15. Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: where we are now?
Liberopoulos EN; Elisaf MS; Tselepis AD; Archimandritis A; Kiskinis D; Cokkinos D; Mikhailidis DP
Platelets; 2006 Feb; 17(1):1-6. PubMed ID: 16308180
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitors reduce the long-term risk of recurrent upper gastrointestinal bleeding: an observational study.
Massó González EL; García Rodríguez LA
Aliment Pharmacol Ther; 2008 Sep; 28(5):629-37. PubMed ID: 18616644
[TBL] [Abstract][Full Text] [Related]
17. Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment.
Lanas A; Scheiman J
Curr Med Res Opin; 2007 Jan; 23(1):163-73. PubMed ID: 17257477
[TBL] [Abstract][Full Text] [Related]
18. Management of patients with high gastrointestinal risk on antiplatelet therapy.
Cryer B
Gastroenterol Clin North Am; 2009 Jun; 38(2):289-303. PubMed ID: 19446259
[TBL] [Abstract][Full Text] [Related]
19. Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy.
Taha AS; Angerson WJ; Knill-Jones RP; Blatchford O
Aliment Pharmacol Ther; 2006 Feb; 23(4):489-95. PubMed ID: 16441469
[TBL] [Abstract][Full Text] [Related]
20. Significant gastrointestinal bleeding in patients at risk of coronary stent thrombosis.
Dai X; Makaryus AN; Makaryus JN; Jauhar R
Rev Cardiovasc Med; 2009; 10(1):14-24. PubMed ID: 19367228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
